News

Pediatric patients exhibited high risk for severe avian influenza A/H5N1, suggesting clinical therapeutic and vaccine trials should be prioritized in this population.
The bird flu virus remains a wild card that continues to threaten U.S. poultry and egg supplies while upping the ante with risk to human health.
The federal government should be investing and working to expand the nation’s scientific and public health arsenal, not ...
A team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously ...
Highly pathogenic avian influenza reached Antarctica’s mainland in early 2024, leaving Australia, New Zealand and Pacific ...
The Department of Health and Human Services is ending a $766 million contract with the vaccine company Moderna to develop an ...
An 11-year-old boy from Cambodia's Kampong Speu province died of H5N1 human avian influenza, becoming the fourth human death from the virus so far this year, the country's Ministry of Health said in ...
An 11-year-old boy from western Cambodia''s Kampong Speu province had died of H5N1 human avian influenza, becoming the fourth ...
Latvia has reported a first outbreak of highly pathogenic H5N1 avian influenza among poultry, Reuters reported, citing the ...
A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, ...
Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the ...
A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, ...